Exact Sciences Corp

EXK

Company Profile

  • Business description

    Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

  • Contact

    5505 Endeavor Lane
    MadisonWI53719
    USA

    T: +1 608 284-5700

    E: [email protected]

    https://www.exactsciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    7,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,723.5017.90-0.20%
CAC 407,589.6636.210.48%
DAX 4023,350.55293.171.27%
Dow JONES (US)42,157.8513.81-0.03%
FTSE 1008,774.6517.15-0.20%
HKSE23,530.48292.741.26%
NASDAQ19,424.07122.21-0.63%
Nikkei 22538,403.2385.11-0.22%
NZX 50 Index12,569.0558.27-0.46%
S&P 5005,960.4720.40-0.34%
S&P/ASX 2008,505.5018.20-0.21%
SSE Composite Index3,359.902.21-0.07%

Market Movers